Abstract
The interaction of immunoglobulin E and otherwise harmless antigens (allergens) leads in sensitized individuals through effector cell activation to the immediate induction of a cascade of inflammatory reactions, the hallmark of type I allergy. Recently, the molecular and structural characterization of allergens, specific IgE antibodies and their epitopes has made rapid progress. Here we discuss active and passive strategies for therapy of type I allergy, which are based on interfering with the IgE-allergen interaction.
Original language | English (US) |
---|---|
Pages (from-to) | 167-176 |
Number of pages | 10 |
Journal | International Archives of Allergy and Immunology |
Volume | 116 |
Issue number | 3 |
DOIs | |
State | Published - Jul 1998 |
Keywords
- Blocking antibody
- Immunoglobulin E
- Immunotherapy
- Recombinant allergens
- Type I allergy
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology